Stay updated with breaking news from Pneumococcal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
KENILWORTH (NJ) (dpa-AFX) - The U.S. Food and Drug Administration has approved an expanded indication for Vaxneuvance (Pneumococcal 15-valent Conjugate Vaccine) to include children 6 weeks through
KENILWORTH (NJ) (dpa-AFX) - Merck & Co., Inc. (MRK) said it has presented positive results from the phase 1/2 study, dubbed as V116-001, evaluating the safety, tolerability and immunogenicity of
NEW YORK CITY (dpa-AFX) - On this day last year, i.e., June 8, 2021, the FDA approved Pfizer Inc.'s (PFE) Prevnar 20 vaccine to prevent pneumonia and invasive disease caused by 20 types of pneumococcal
BOULDER, Colo., May 10, 2022for rapid and accurate assessment of pneumococcal vaccines at all stages of manufacturing, including multivalent drug product. This launch is accompanied by the availability
KENILWORTH (NJ) (dpa-AFX) - Merck & Co. Inc. (MRK) said that its investigational 21-valent pneumococcal conjugate vaccine ,V116, has received Breakthrough Therapy Designation from the U.S. Food